Obesity Treatment Market Research Report – Forecast to 2027

Obesity Treatment Market Research Report, by Type (Inactivity, Obesity gluten, Obesity), Diagnosis (Blood Tests, Physical Examination), Treatment (Medication, Surgery, Lifestyle Changes), End-Users (Hospitals, Clinics) - Forecast Till 2027

ID: MRFR/Pharma/4416-HCR | February 2021 | Region: Global | 100 pages

Obesity Treatment Market Overview:


The Obesity Treatment Market is projected to grow at a CAGR of 16.7% during forecast period. Obesity is considered a global disorder as obesity is the primary cause of several other health concerns. Obesity is characterized by the Body Mass index and has several causes in general. The key causes for obesity are socio-economic conditions, mental disorders, medications, improper diet, and lack of physical exercise, endocrine disorders, urbanization, and economic conditions. Proper diet control includes lower energy foods, lower sugar and fat content. If obesity is growing beyond control, medical professionals might recommend medications according to the patients’ condition to control appetite or decrease fat absorption. 


World health organization has claimed that over 13% of the world’s population is obese and risks associated with obesity have increased the overall demand for the Obesity Treatment Market. People who have cardiovascular issues and greater degrees of obesity are more likely to have frequent cardiovascular events than those with normal weight. Such factors have increased the necessity of maintaining body mass index. With the increasing options of treating the condition, the Obesity Treatment industry is likely to witness steady growth in the forecast period.


COVID 19 Analysis:


The pandemic hit has affected almost every industrial and commercial unit across the globe. Some medical branches have also experienced a significant decline due to the COVID 19. The restrictions in the movement have restricted people from visiting hospitals for regular health checkups and conditions like obesity treatments. There was a significant decline in obesity drug management and subscriptions in recent years. Additionally, the surgeries related to obesity issues have been postponed to attend to the ongoing crisis.


However, the advent of technology consultants and sedentary lifestyle, work from home trends has propelled the overall growth of the Obesity treatment market demand.


Obesity Treatment Market Dynamics:


Market drivers:


The work-from-home trends and lack of physical exercise, unhealthy diet, and routines have increased the rate of obesity in recent times. Improper food habits and trends like ordering food online and increasing packed food and ready-to-eat food packages trends have created a huge impact over a wide scale of the population. The Institute of Health Metrics and Evaluation has claimed that over 30% of the world population is categorized as obese or overweight. Such factors and reports have propelled the demand for the Obesity Treatment industry.


Rising weight management programs, applications, and websites that guide and monitor the regular activity of the individual have promoted the awareness among the population about the concerns associated with overweight. Surging electronic devices and wearables that constantly monitor the health parameters have also created a huge impact on the growth of the Obesity Treatment industry in recent years.


Market opportunities:


The advancements in the surgeries and devices utilized in surgeries related to obesity treatment have bolstered the growth of the Obesity treatment industry in recent years. The U.S National Institute of Health has recommended Bariatric surgeries for obese people whose body mass index is above 40. With the positive recommendations of medical associations and initiatives, the obesity treatment market is expected to have a steady growth in the forecast period.


The analysis done on bariatric surgery has proven that the life expectancy of the patients who have undergone bariatric surgery has been increased by 9.3 years. The reduction in cardiovascular events and diabetes-related complications after undergoing bariatric surgery is considered the primary driving factor for the Obesity Treatment industry. 


Market restraints:


The medications such as Lorcaserin and Phentermine-topiramate are highly associated with factors causing heart valve problems. The American Association has removed Lorcaserin from the market in the year 2020 since the medication is associated with cancer-causing agents. Orlistat is highly associated with the factors causing gastrointestinal side effects. These reports have adversely impacted the Obesity Treatment market growth in recent years.


After acquiring the obesity treatment, there are about 17% chances for complications and 7% chances for reoperation. Such factors are considered as the primary restraints of the growth of the Obesity market growth.


Market challenges:


The cost incurred for the Obesity treatment ranges between USD 1239 to USD 2582 per person per year, excluding the miscellaneous expenses associated with the treatment. Moreover, developing countries don’t provide reimbursement facilities for these procedures. They are considered as the major challenges for the growth of the Obesity Treatment market.


The risks of getting infections and allergic to the medications and side effects associated with the treatment are also considered as challenges for the growth of the Obesity Treatment market. After undergoing costlier treatments, gaining weight after surgery is significantly impacting the growth of the Obesity Treatment market.


Cumulative growth analysis:


Over other significant causes, Malnutrition at the early stages of life is playing a crucial role in gaining weight. Since the major endocrine changes that occur during the period of malnutrition tend to accumulate more fat once it becomes available. On the other hand, changing trends in lifestyle, urbanization is considered as the primary reasons for the Obesity treatment market. 


The restrictions in movements due to the pandemic have further bolstered the overall growth of the Obesity treatment market in several countries.


Dieting is a lifestyle change and regular physical exercise has a huge impact on controlling body weight. Continuous energy restriction and hypo-caloric diets are recommended by professionals to attain weight loss goals. Smoking and decreased intake of sweet or aerated drinks are highly associated with obesity. The surging awareness of the condition, even in developing countries has a significant impact on the overall growth of the Obesity Treatment industry.


Value chain analysis:


The gastric bypass surgery which bypasses the food, and reduces the size of the stomach thereby showcases significant results in acquiring weight loss. However, the huge risk of not absorbing essential nutrients and minerals is accompanied by the procedure. Recently, medical professionals are more likely advising bariatric surgery for treating obesity.


The increasing prevalence of conditions like type-2 diabetes, high blood pressure, cardiovascular problems that are highly associated with obesity are the primary drivers of the Obesity Treatment market growth. On the other hand, minimally invasive endoscopic procedures are also driving market growth in recent years. 


Segment overview:


Based on Surgery Type:



  • Biliopancreatic diversion with Duodenal Switch (BPD/DS)

  • Adjusting Gastric Banding

  • Roux-en-Y Gastric Bypass

  • Sleeve gastrectomy

  • Endoscopic Procedures


Based on Drug Type:



  • Appetite suppressants

  • Combination drugs

  • Malabsorption

  • Satiety drugs


Based on End-user:



  • Clinics

  • Hospitals

  • Beauty institutions

  • Others


Figure 1- Global Obesity Treatment Market Share, by Region


 Obesity Treatment Market


Sources: Obesity Surgery journal, Eurostat, Monash University annual reports, press release, white paper, and company presentation


Regional analysis:


Urbanization is considered as one of the primary causes of Obesity. Hence North America is accounting for the largest market share with over 53% in recent times. Additionally, the higher R&D developments, minimally invasive procedures, and effective weight management solutions in the region are considered as the primary factors that are bolstering the Obesity Treatment market growth.


Asia-pacific is accounting for over 18% of CAGR in recent years owing to the increasing awareness about the health issues associated with obesity and social media exposure. The advancing medical facilities and infrastructure in the region are also the primary reasons for the growth of the Obesity Treatment Market in these regions.


Competitive Landscape:



  • VIVUS, Inc. (U.S.)

  • Arena Pharmaceuticals, Inc. (U.S.)

  • F. Hoffmann-La Roche, Ltd. (Switzerland)

  • Novo Nordisk A/S (Denmark)

  • Orexigen Therapeutics, Inc. (U.S.)

  • Allergan (Republic of Ireland)

  • Cousin Biotech (France)

  • EnteroMedics, Inc. (U.S.)

  • Johnson & Johnson Services, Inc. (U.S.)

  • Medtronic (U.S.)

  • USGI Medical, Inc. (U.S.)

  • Mediflex Surgical Products (U.S.)

  • Covidien plc (Republic of Ireland)

  • Olympus Corporation (Japan)

  • Takeda Pharmaceuticals Company Limited

  • Eisai Co. Ltd.

  • Novo Nordisk A/S

  • Zafgen

  • Rhythm Pharmaceuticals

  • Zydus Cadila

  • Norgine B.V.

  • Vivus Therapeutics

  • Arena Pharmaceuticals Inc.

  • Orexigen Therapeutics Inc


Recent developments:


Semaglutide 2.4 mg which is a recently approved agent which is recommended once every week has been effective in chronic weight management in adults. About 33% of the participants who have been administered the drug have lost over 20% of body weight in 68 weeks. 


Saxenda, which is also known as Liraglutide 3mg, is recently recommended by NICE has increased the number of patients who are expected to be benefitted during the pandemic. 


Report Overview:


This report has covered:



  • Market overview

  • COVID 19 Analysis

  • Market dynamics

  • Cumulative growth analysis

  • Value chain analysis

  • Segment overview

  • Regional analysis

  • Competitive landscape

  • Recent developments



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   16.7% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment, and End-user.
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   VIVUS, Inc. (U.S.), Arena Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Orexigen Therapeutics, Inc. (U.S.), Allergan (Republic of Ireland), Cousin Biotech (France), EnteroMedics, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Medtronic (U.S.), USGI Medical, Inc. (U.S.), Mediflex Surgical Products (U.S.), Covidien plc (Republic of Ireland), Olympus Corporation (Japan), and others.
  Key Market Opportunities

  • Growing obese population
  • Increasing acceptance of bariatric surgeries
  •   Key Market Drivers

  • Increasing demand for minimally invasive surgeries
  • Rising awareness
  • Favorable reimbursement policies


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    On the basis of treatment, the Obesity Treatment Market is segmented into medication, surgery, lifestyle changes, and others.

    The Obesity Treatment Market is expected to exhibit a strong 16.7% CAGR over the forecast period till 2027.

    The growing prevalence of obesity is the major driver for the market.

    North America is the leading regional market for obesity treatment.

    Leading players in the Obesity Treatment Market include Novo Nordisk, Arena Pharmaceuticals, and Allergan, among others.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Obesity Treatment Market, by Type

    6.1 Introduction

    6.2 Inactivity Obesity

    Market Estimates & Forecast, 2020–2027

    6.3 Food Obesity

    Market Estimates & Forecast, 2020–2027

    6.4 Anxiety Obesity

    Market Estimates & Forecast, 2020–2027

    6.5 Venous Obesity

    Market Estimates & Forecast, 2020–2027

    6.6 Atherogenic Obesity

    Market Estimates & Forecast, 2020–2027

    6.7 Gluten Obesity

    Market Estimates & Forecast, 2020–2027

    Chapter 7. Global Obesity Treatment Market, by Diagnosis

    7.1 Introduction

    7.2 Blood Tests

    Market Estimates & Forecast, 2020–2027

    7.2.1 Cholesterol Tests

    7.2.2 Liver Function Tests

    7.2.3 Thyroid Tests

    7.3 Physical Examination

    Market Estimates & Forecast, 2020–2027

    7.3.1 Heart Rate Measurement

    7.3.2 Blood Pressure Measurement

    7.3.3 Others

    7.4 Others

    Chapter 8. Global Obesity Treatment Market, by Treatment

    8.1 Introduction

    8.2 Medication

    Market Estimates & Forecast, 2020–2027

    8.2.1 Orlistat

    8.2.2 Lorcaserin

    8.2.3 Phentermine and Topiramate

    8.2.4 Liraglutide

    8.2.5 Others

    8.3 Surgery

    Market Estimates & Forecast, 2020–2027

    8.3.1 Gastric Bypass Surgery

    8.3.2 Laparoscopic Adjustable Gastric Banding (LAGB)

    8.3.3 Gastric Sleeve

    8.3.4 Biliopancreatic Diversion

    8.3.5 Gastric Sleeve

    8.3.6 Others

    8.4 Lifestyle Changes

    8.5 Others

    Chapter 9. Global Obesity Treatment Market, by End-User

    9.1 Introduction

    9.2 Hospitals

    Market Estimates & Forecast, 2020–2027

    9.3 Clinics

    Market Estimates & Forecast, 2020–2027

    9.4 Pharmacies

    Market Estimates & Forecast, 2020–2027

    9.5 Others

    Chapter 10. Global Obesity Treatment Market, by Region

    10.1 Introduction

    10.2 America

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 U.K.

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    Chapter 12 Company Profiles

    12.1 VIVUS, Inc.

    12.1.1 Company Overview

    12.1.2 Type Overview

    12.1.3 Financials

    12.2.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Arena Pharmaceuticals, Inc.

    12.2.1 Company Overview

    12.2.2 Type Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 F. Hoffmann-La Roche, Ltd.

    12.3.1 Company Overview

    12.3.2 Type Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Novo Nordisk A/S

    12.4.1 Company Overview

    12.4.2 Type/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Orexigen Therapeutics, Inc.

    12.5.1 Company Overview

    12.5.2 Type Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 Allergan

    12.6.1 Company Overview

    12.6.2 Type Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Cousin Biotech

    12.7.1 Overview

    12.7.2 Type Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 EnteroMedics, Inc.

    12.8.1 Overview

    12.8.2 Type Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Johnson & Johnson Services, Inc.

    12.9.1 Overview

    12.9.2 Type Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Medtronic

    12.10.1 Overview

    12.10.2 Type Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 USGI Medical, Inc.

    12.11.1 Overview

    12.11.2 Type Overview

    12.11.3 Financials

    12.11.4 Key Developments

    12.11.5 SWOT Analysis

    12.12 Mediflex Surgical Products

    12.12.1 Overview

    12.12.2 Type Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    12.13 Covidien plc

    12.13.1 Overview

    12.13.2 Type Overview

    12.13.3 Financials

    12.13.4 Key Developments

    12.13.5 SWOT Analysis

    12.14 Olympus Corporation

    12.14.1 Overview

    12.14.2 Type Overview

    12.14.3 Financials

    12.14.4 Key Developments

    12.14.5 SWOT Analysis

    12.15 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Global Obesity Treatment Market

    Chapter 14 Appendix

    LIST OF TABLES

    Table 1 Obesity Treatment Industry Synopsis, 2020–2027

    Table 2 Global Obesity Treatment Market Estimates & Forecast, 2020–2027, (USD Million)

    Table 3 Global Obesity Treatment Market, by Region, 2020–2027, (USD Million)

    Table 4 Global Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 5 Global Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 6 Global Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 7 Global Obesity Treatment Market, by End-User, 2020–2027, (USD Million

    Table 8 North America Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 9 North America Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 10 North America Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 11 North America Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 12 U.S. Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 13 U.S. Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 14 U.S. Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 15 U.S. Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 16 Canada Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 17 Canada Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 18 Canada Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 19 Canada Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 20 South America Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 21 South America Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 22 South America Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 23 South America Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 24 Europe Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 25 Europe Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 26 Europe Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 27 Europe Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 28 Western Europe Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 29 Western Europe Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 30 Western Europe Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 31 Western Europe Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 32 Eastern Europe Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 33 Eastern Europe Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 34 Eastern Europe Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 35 Eastern Europe Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 36 Asia Pacific Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 37 Asia Pacific Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 38 Asia Pacific Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 39 Asia Pacific Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 40 The Middle East & Africa Obesity Treatment Market, by Type, 2020–2027, (USD Million)

    Table 41 The Middle East & Africa Obesity Treatment Market, by Diagnosis, 2020–2027, (USD Million)

    Table 42 The Middle East & Africa Obesity Treatment Market, by Treatment, 2020–2027, (USD Million)

    Table 43 The Middle East & Africa Obesity Treatment Market, by End-User, 2020–2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Obesity Treatment Market

    Figure 3 Market Dynamics for Global Obesity Treatment Market

    Figure 4 Global Obesity Treatment Market Share, by Type 2020

    Figure 5 Global Obesity Treatment Market Share, by Diagnosis 2020

    Figure 6 Global Obesity Treatment Market Share, by Treatment, 2020

    Figure 7 Global Obesity Treatment Market Share, by End-User, 2020

    Figure 8 Global Obesity Treatment Market Share, by Region, 2020

    Figure 9 North America Obesity Treatment Market Share, by Country, 2020

    Figure 10 Europe Obesity Treatment Market Share, by Country, 2020

    Figure 11 Asia Pacific Obesity Treatment Market Share, by Country, 2020

    Figure 12 The Middle East & Africa Obesity Treatment Market Share, by Country, 2020

    Figure 13 Global Obesity Treatment Market: Company Share Analysis, 2020 (%)

    Figure 14 VIVUS, Inc.: Key Financials

    Figure 15 VIVUS, Inc.: Segmental Revenue

    Figure 16 VIVUS, Inc.: Geographical Revenue

    Figure 17 Arena Pharmaceuticals, Inc.: Key Financials

    Figure 18 Arena Pharmaceuticals, Inc.: Segmental Revenue

    Figure 19 Arena Pharmaceuticals, Inc.: Geographical Revenue

    Figure 20 F. Hoffmann-La Roche, Ltd.: Key Financials

    Figure 21 F. Hoffmann-La Roche, Ltd.: Segmental Revenue

    Figure 22 F. Hoffmann-La Roche, Ltd.: Geographical Revenue

    Figure 23 Novo Nordisk A/S: Key Financials

    Figure 24 Novo Nordisk A/S: Segmental Revenue

    Figure 25 Novo Nordisk A/S: Geographical Revenue

    Figure 26 Orexigen Therapeutics, Inc.: Key Financials

    Figure 27 Orexigen Therapeutics, Inc.: Segmental Revenue

    Figure 28 Orexigen Therapeutics, Inc.: Geographical Revenue

    Figure 29 Allergan: Key Financials

    Figure 30 Allergan: Segmental Revenue

    Figure 31 Allergan: Geographical Revenue

    Figure 32 Cousin Biotech: Key Financials

    Figure 33 Cousin Biotech: Segmental Revenue

    Figure 34 Cousin Biotech: Geographical Revenue

    Figure 35 EnteroMedics, Inc.: Key Financials

    Figure 36 EnteroMedics, Inc.: Segmental Revenue

    Figure 37 EnteroMedics, Inc.: Geographical Revenue

    Figure 38 Johnson & Johnson Services, Inc.: Key Financials

    Figure 39 Johnson & Johnson Services, Inc.: Segmental Revenue

    Figure 40 Johnson & Johnson Services, Inc.: Geographical Revenue

    Figure 41 Medtronic: Key Financials

    Figure 42 Medtronic: Segmental Revenue

    Figure 43 Medtronic: Geographical Revenue

    Figure 44 USGI Medical, Inc.: Key Financials

    Figure 45 USGI Medical, Inc.: Segmental Revenue

    Figure 46 USGI Medical, Inc.: Geographical Revenue

    Figure 47 Mediflex Surgical Products: Key Financials

    Figure 48 Mediflex Surgical Products: Segmental Revenue

    Figure 49 Mediflex Surgical Products: Geographical Revenue

    Figure 50 Covidien plc: Key Financials

    Figure 51 Covidien plc: Segmental Revenue

    Figure 52 Covidien plc: Geographical Revenue

    Figure 53 Olympus Corporation: Key Financials

    Figure 54 Olympus Corporation: Segmental Revenue

    Figure 55 Olympus Corporation: Geographical Revenue